MARKET IS CLOSED
Loading latest tickers...
Market Indices
S&P 500
$7,722.72
+0.73%
NASDAQ 100
$30,807.93
+1.00%
DOW JONES
$51,177.00
+0.49%
NASDAQ Composite
$27,190.86
+1.19%
RUSSELL 2000
$2,815.20
+0.90%
CBOE VIX
$15.31
-6.59%
Sector Heatmap
Technology+1.01%
Financials+0.06%
Healthcare-0.01%
Consumer Cycl+1.13%
Consumer Staples+0.25%
Energy+0.40%
Industrials+0.78%
Materials+0.66%
Real Estate+0.32%
Utilities+0.38%
Comm Services+0.35%
ATRA — Atara Biotherapeutics, Inc
NasdaqAtara Biotherapeutics, Inc
$9.48
+1.02(+12.06%)
- O
- 8.46
- H
- 9.68
- L
- 8.25
- V
- 85.64K
⏱️ End-of-day dataAs of Oct 2, 2026
Chart
About ATRA
Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA3431, and ATA3219.
IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
SectorNot available
IPO DateOct 16, 2014
Employees10
Stock ExchangeNasdaq
Ticker SymbolATRA
Websitehttps://www.atarabio.com
Key Financial Statistics
| Market Cap | $88.43M |
| P/E Ratio | N/A |
| Dividend Yield | None |
| EPS | N/A |
| Beta | N/A |
| 52-Week Range | $3.92 - $19.15 |
| 52-Week Avg Volume | 492.6K |
| VWAP | $9.35 |
| Transactions | 1,871 |
| Total Recorded Bars | 3,008 days |